Related Experiment Video

Updated: Jul 14, 2026

Development and Application of Rapamycin-regulated Tyrosine Phosphatases
06:56

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Mammalian target of rapamycin: master regulator of cell growth in the nervous system

D K Sandsmark1, C Pelletier, J D Weber

  • 1Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.

Histology and Histopathology
|May 16, 2007
PubMed

Insights

The mammalian target of rapamycin (mTOR) pathway regulates cell growth. Its hyperactivation is linked to brain tumors in inherited cancer syndromes, suggesting mTOR as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The mammalian target of rapamycin (mTOR) is a kinase regulating cell growth, proliferation, ribosomal biogenesis, and protein translation.
  • Hyperactivation of the mTOR signaling pathway is implicated in various human cancers, including inherited cancer syndromes.
  • Three specific inherited cancer syndromes—Lhermitte-Duclos disease, neurofibromatosis type 1, and tuberous sclerosis complex—are associated with central nervous system dysfunction and brain tumors.

Purpose of the Study:

  • To review the current understanding of the mTOR signaling pathway.
  • To elucidate the role of mTOR in ribosome biogenesis and cell growth.
  • To explore the potential of targeting the mTOR pathway for brain tumor therapies.

Main Methods:

  • Literature review of studies on mTOR signaling.
  • Analysis of genetic mutations affecting mTOR regulation in inherited cancer syndromes.
  • Discussion of mTOR's role in central nervous system development and function.

Main Results:

  • Genetic mutations disrupting negative mTOR regulators are linked to Lhermitte-Duclos disease, neurofibromatosis type 1, and tuberous sclerosis complex.
  • These mutations lead to mTOR hyperactivation, contributing to brain tumor formation.
  • The mTOR pathway is critical for normal brain development and function.

Conclusions:

  • The mTOR signaling pathway plays a crucial role in brain development and is implicated in brain tumors.
  • Understanding mTOR's function may identify molecular targets for treating brain tumors in inherited syndromes and sporadic cases.
  • Targeting mTOR signaling presents a potential therapeutic strategy for central nervous system tumors.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...